Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

According to clinicaltrials.gov the trial is still

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
(Total Views: 354)
Posted On: 03/08/2018 3:05:06 PM
Avatar
Posted By: redspeed
Re: freegriff #26209
According to clinicaltrials.gov the trial is still active, not recruiting, at least that's the recruitment status.

https://www.clinicaltrials.gov/ct2/show/NCT02...amp;rank=2

We do know at least one patient that was dosed.

Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia

https://www.amarantus.com/news/press-releases...ltoprazine

Yes, they did stop the recruitment, but I always wondered what happen to the people that started taking the drug.

A. Do they chase after them and say "spit it out"?
B. Give them a call and say "You know those pills we gave you last month. You might want to just stop taking them."
C. Tell them to go to Europe because the the trial is continuing there for a awhile longer.
D. Give them their business card and say "Off the record tell me how you re feeling when you run out of pills in 6 months."

Here's another trial that uses the world enabling, but slightly different.

Quote:
The CIT-07 trial was designed to be a license-enabling multicenter phase 3 clinical trial of a standardized, well-defined islet product, using a stringently defined, clinically relevant primary end point.


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317236/

At least they spelled "trial" right. You know there's someone that spells it as "trail" but they are an emotional basket case.

4729688_orig.jpg















(4)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us